← Dashboard
Nov 19, 2026 05:17 AM ET
Signal
Corporate
Emmaus Life Sciences GAAP EPS of -$0.07, revenue of $1.9M
Emmaus Life Sciences reported GAAP EPS of -$0.07 and revenue of $1.9M.
What changed
Emmaus Life Sciences reported GAAP EPS of -$0.07 and revenue of $1.9M.
Why it matters
Emmaus Life Sciences reported GAAP EPS of -$0.07 and revenue of $1.9M. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →
FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →
$FMX →